Healthpeak Properties, Inc. (Old)

As of February 3, 2025, Healthpeak Properties, Inc. is considered very attractive in valuation despite underperforming the S&P 500, with a P/E ratio of 38 compared to peers and a favorable EV to EBITDA ratio of 7.48, suggesting it may be undervalued at its current price of 18.57.

As of April 24, 2025, Healthpeak Properties, Inc. is in a bearish trend with moderate strength, indicated by bearish MACD, moving averages, and KST, along with mildly bearish signals from Bollinger Bands and Dow Theory.

As of February 3, 2025, Healthpeak Properties, Inc. is considered a very attractive investment due to its undervaluation indicated by a high P/E ratio of 38 compared to peers, a favorable EV to EBITDA ratio of 7.48, and strong growth prospects despite recent underperformance against the S&P 500.

As of March 2022, the management team of Healthpeak Properties, Inc. includes Mr. Brian Cartwright (Independent Chairman), Mr. Thomas Herzog (CEO), and six independent directors: Ms. Christine Garvey, Mr. R. Kent Griffin, Ms. Sara Grootwassink Lewis, Mr. David Henry, and Ms. Lydia Kennard. This diverse team oversees the company's governance and strategic direction.

Healthpeak Properties, Inc. (Old) is a mid-cap real estate investment trust focused on healthcare-related real estate in the U.S., with recent net sales of $703 million and a market cap of approximately $11.9 billion. Key metrics include a P/E ratio of 38.00 and a dividend yield of 5.95%.

As of Jun 18, Healthpeak Properties, Inc. (Old) has a market capitalization of $11.90 billion, with net sales of $2.80 billion and a net profit of $305.16 million over the latest four quarters. Shareholder's funds total $8.40 billion, and total assets are reported at $19.94 billion as of Dec'24.